Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FQHBX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,792
Award facts
- Contract value 100% obligated
- $20,792.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,792.03 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on July 23, 2025, with completion scheduled for July 24, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor and healthcare solutions provider, fulfills critical supply chain roles across the Defense Health Agency and military healthcare systems. The company's DLA Troop Support Medical IDC enables it to supply a diverse portfolio of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, and medical devices—to support military healthcare programs globally. This delivery order for Gemtesa, a medication used in the treatment of overactive bladder, exemplifies the routine pharmaceutical procurement conducted under this broader contract vehicle, demonstrating AmerisourceBergen's continued role as a prime vendor in federal military medical supply chains.
Quick answers
Who was awarded contract SPE2DB25FQHBX?
SPE2DB25FQHBX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FQHBX worth?
The government has obligated $20,792 on SPE2DB25FQHBX.
Is contract SPE2DB25FQHBX an order under another contract?
Yes. SPE2DB25FQHBX is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQHBX competed?
The extent of competition for SPE2DB25FQHBX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award